Semler Scientific, Inc.

SMLR

Semler Scientific, Inc.

SMLR

Insider Sentiment (TTM):

Last Purchase:2024-11-07Last Sale:2025-11-17Shares Purchased (TTM):0Shares Sold (TTM):70,406

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:10,609,370Shares Outstanding:14,848,408Institutional Ownership Pct.:71.45%

Earnings Market Reaction:

Filing Date:2025-11-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	10	13	10	9	7	7	63	57	37	39	5	23
Short Term Investments	-	-	-	-	-	-	-	-	19	12	38	20
Restricted Cash Current	0	0	0	0	0	0	0	0	-	-	-	-
Deposits Assets Current	0	0	0	-	-	-	-	-	-	-	-	-
Accounts Receivable Net Current	3	3	3	4	7	7	6	6	6	6	9	4
Notes And Loans Receivable Net Current	-	-	-	6	6	6	-	-	-	-	-	-
Inventory Net	0	1	0	0	0	0	0	0	0	0	1	0
Prepaid Expense And Other Assets Current	4	5	5	3	2	2	2	2	2	2	3	1
Assets Current	54	22	18	23	21	24	72	66	64	61	56	49
Property Subject To Or Available For Operating Lea…	1	1	1	1	2	2	2	2	2	3	3	2
Property Plant And Equipment Excluding Lessor Asse…	0	0	0	0	1	1	1	1	1	1	1	1
Long Term Investments	1	1	1	1	1	1	1	1	1	1	1	1
Notes And Loans Receivable Net Noncurrent	1	2	2	-	-	-	5	5	5	5	5	5
Crypto Asset Fair Value Noncurrent	540	497	264	215	64	55	-	-	-	-	-	-
Other Assets Noncurrent	0	0	0	0	0	0	0	0	3	3	3	3
Deferred Income Tax Assets Net	-	-	8	-	3	3	3	3	3	3	2	2
Assets	597	523	293	240	92	85	84	78	79	75	70	63
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	0	0	1	0	1	0	0	0	0	1	0	1
Accrued Liabilities Current	6	6	4	5	5	5	4	5	7	8	7	5
Loss Contingency Accrual Carrying Value Current	-	30	30	-	-	-	-	-	-	-	-	-
Contract With Customer Liability Current	0	1	1	1	1	1	1	1	1	1	1	1
Short Term Borrowings	20	-	-	-	-	-	-	-	-	-	-	-
Other Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	27	37	36	6	7	6	6	6	9	10	9	7
Liabilities Noncurrent
Other Liabilities Noncurrent	-	-	-	-	-	0	0	0	0	0	0	0
Deferred Income Tax Liabilities Net	13	6	-	3	-	-	-	-	-	-	-	-
Convertible Debt Noncurrent	96	96	96	-	-	-	-	-	-	-	-	-
Liabilities Noncurrent	110	102	96	3	-	0	0	0	0	0	0	0
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	340	280	126	130	14	13	12	12	15	15	17	16
Retained Earnings Accumulated Deficit	120	103	36	101	71	66	66	60	56	50	44	39
Stockholders Equity	460	383	162	231	85	78	78	72	71	65	61	56
Liabilities And Stockholders Equity	597	523	293	240	92	85	84	78	79	75	70	63
Allowance For Doubtful Accounts Receivable Current	0	0	0	0	0	0	0	0	0	0	0	0
Notes Receivable Fair Value Disclosure	-	-	-	-	-	-	4	4	4	4	4	4
Deferred Tax Assets Valuation Allowance	-	-	-	-	1	1	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Common Stock Shares Issued	15	14	10	10	7	7	7	7	7	7	7	7
Shares Outstanding	15	14	10	10	7	7	7	7	7	7	7	7
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	-10.14%	10.22%	-6.10%	-16.20%	-19.96%	-32.26%	-27.44%	-30.90%	-	-	-	-
2024	39.47%	63.58%	58.73%	-2.98%	-13.63%	-0.36%	46.21%	62.23%	42.21%	-8.62%	-24.31%	-4.75%
2023	-5.19%	-11.62%	-18.02%	-8.12%	-1.62%	7.10%	31.04%	28.10%	31.62%	-8.20%	-17.94%	-26.71%
2022	-	-	-	-	-	-	-	-	-	-5.36%	15.39%	2.02%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	1.97	0.60	0.52	3.59	3.14	3.72	12.18	10.64	7.51	6.03	6.23	7.13
Quick Ratio	1.80	0.45	0.37	3.08	2.85	3.31	11.69	10.24	7.23	5.74	5.87	6.85
Working Capital	26.29M	-14.87M	-17.22M	16.38M	14.66M	17.33M	66.00M	59.74M	55.80M	50.67M	46.67M	42.05M
Leverage & Debt
Debt to Equity	0.30	0.36	0.81	0.04	0.08	0.08	0.08	0.09	0.12	0.16	0.15	0.13
Interest Coverage TTM	-9.56	-10.88	-9.39	12.31	11.71	9.50	10.90	12.55	11.04	13.79	19.98	34.82
Debt Ratio	0.23	0.27	0.45	0.04	0.07	0.08	0.07	0.08	0.11	0.14	0.13	0.11
Efficiency & Turnover
Asset Turnover TTM	0.11	0.14	0.26	0.35	0.69	0.77	0.85	0.97	0.95	0.97	0.97	1.00
Days Sales Outstanding TTM	45.55	43.74	34.37	34.05	39.12	39.91	42.87	26.79	26.29	32.68	44.25	24.16
Receivables Turnover TTM	8.01	8.34	10.62	10.72	9.33	9.15	8.51	13.62	13.89	11.17	8.25	15.11
Per Share Metrics
Diluted EPS TTM	2.92	2.75	-3.11	5.13	2.05	2.03	2.79	2.63	2.50	2.25	2.02	1.79
Free Cash Flow Per Share TTM	-1.81	1.06	1.75	3.36	3.02	2.84	3.75	3.12	2.71	3.18	2.44	2.53
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	90.76%	90.85%	90.96%	91.55%	88.05%	88.67%	89.43%	89.76%	92.86%	92.56%	92.52%	92.50%
Operating Profit Margin TTM	-94.71%	-57.12%	-34.83%	37.19%	33.79%	34.25%	34.88%	32.64%	34.89%	33.28%	32.06%	30.35%
Net Profit Margin TTM	130.80%	86.20%	-60.69%	72.65%	27.00%	25.62%	32.92%	30.19%	29.25%	27.44%	26.17%	25.27%
Growth Metrics
Net Revenue Growth (1Y)	-37.29%	-30.39%	-25.28%	-17.44%	-11.93%	-4.50%	8.22%	20.28%	22.94%	18.90%	13.03%	6.90%
Net Income Growth (1Y)	203.75%	134.19%	-237.76%	98.70%	-18.71%	-10.82%	36.11%	43.69%	55.18%	35.51%	1.46%	-16.82%
EPS Growth (1Y)	44.12%	38.68%	-198.95%	85.06%	-22.50%	-13.87%	32.32%	43.56%	54.28%	36.59%	2.62%	-16.76%
Calculated Values
Free Cash Flow TTM	-26.93M	12.41M	16.78M	24.31M	21.29M	19.69M	25.84M	20.99M	18.20M	21.31M	16.37M	16.99M
Net Debt	106.11M	82.64M	86.22M	-8.95M	-6.70M	-7.46M	-62.89M	-57.33M	-37.50M	-39.50M	-5.31M	-23.01M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-17Sale

Owner: Murphy-Chutorian, Douglas

Title: CEO, interim CFO and Director

Shares: 70,406

Price/Share: $20.41

Value: $1,436,986.46

Shares Owned: 54,594

Relationship: Director,Officer

Ownership: Direct

2025-08-25Sale

Owner: Murphy-Chutorian, Douglas

Title: Chief Executive Officer

Shares: 28,604

Price/Share: $30.54

Value: $873,566.16

Shares Owned: 31,396

Relationship: Director,Officer

Ownership: Direct

2024-12-11Sale

Owner: Murphy-Chutorian, Douglas

Title: CEO

Shares: 25,000

Price/Share: $61.68

Value: $1,542,000.00

Shares Owned: 55,000

Relationship: Director,Officer

Ownership: Direct

2024-11-07Sale

Owner: Murphy-Chutorian, Douglas

Title: CEO

Shares: 50,000

Price/Share: $37.93

Value: $1,896,500.00

Shares Owned: 50,000

Relationship: Director,Officer

Ownership: Direct

2024-11-07Purchase

Owner: Semler, Eric

Title: -

Shares: 50,000

Price/Share: $37.93

Value: $1,896,500.00

Shares Owned: 621,721

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-17	Murphy-Chutorian, Douglas	Director,Officer	CEO, interim CFO and Director	Direct	Sale	70,406	20.41	$1,436,986.46	54,594	4
2025-08-25	Murphy-Chutorian, Douglas	Director,Officer	Chief Executive Officer	Direct	Sale	28,604	30.54	$873,566.16	31,396	4
2024-12-11	Murphy-Chutorian, Douglas	Director,Officer	CEO	Direct	Sale	25,000	61.68	$1,542,000.00	55,000	4
2024-11-07	Murphy-Chutorian, Douglas	Director,Officer	CEO	Direct	Sale	50,000	37.93	$1,896,500.00	50,000	4
2024-11-07	Semler, Eric	Director	-	Direct	Purchase	50,000	37.93	$1,896,500.00	621,721	4
2024-08-29	Murphy-Chutorian, Douglas	Director,Officer,TenPercentOwner	CEO	Direct	Sale	10,101	28.34	$286,262.34	26,742	4/A
2023-09-13	Semler, Eric	Director	-	Indirect	Purchase	26,868	28.11	$755,259.48	77,771	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

71.45%

Inst. Shares: 10,609,370

Shares Outstanding: 14,848,408

2025-09-30

63.51%

Inst. Shares: 9,429,540

Shares Outstanding: 14,848,408

2025-06-30

78.23%

Inst. Shares: 9,174,732

Shares Outstanding: 11,727,660

2025-03-31

67.14%

Inst. Shares: 6,443,031

Shares Outstanding: 9,596,037

2024-12-31

69.25%

Inst. Shares: 5,006,202

Shares Outstanding: 7,228,961

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	10,609,370	14,848,408	71.45%
2025-09-30	9,429,540	14,848,408	63.51%
2025-06-30	9,174,732	11,727,660	78.23%
2025-03-31	6,443,031	9,596,037	67.14%
2024-12-31	5,006,202	7,228,961	69.25%
2024-09-30	3,670,924	7,045,108	52.11%
2024-06-30	2,895,732	6,944,664	41.70%
2024-03-31	2,887,036	6,892,742	41.89%
2023-12-31	3,061,429	6,732,806	45.47%
2023-09-30	3,115,487	6,717,301	46.38%
2023-06-30	3,667,617	6,707,341	54.68%
2023-03-31	2,975,222	6,701,199	44.40%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Semler Scientific, Inc. (SMLR) — SEC Financial Statements & Analysis

Semler Scientific, Inc. (SMLR) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Semler Scientific, Inc. trades on Nasdaq as: SMLR. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), Semler Scientific, Inc. reported a -37.29% year-over-year revenue growth, a Gross Profit Margin of 90.76% (TTM), a Debt-to-Equity ratio of 0.30x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -37.29%
Gross Profit Margin TTM: 90.76%
Debt To Equity: 0.30x

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Semler Scientific, Inc. in?

Semler Scientific, Inc. (SMLR) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What exchange does SMLR trade on?

Semler Scientific, Inc. (SMLR) trades on the Nasdaq.

Where is Semler Scientific, Inc. incorporated?

Semler Scientific, Inc. is incorporated in DE.